Compound Summary
Compound Information
MINOCYCLINE HYDROCHLORIDE
Compound Name: | MINOCYCLINE HYDROCHLORIDE |
Compound CID: | 54685925 |
Synonyms: | MINOCYCLINE HYDROCHLORIDE 13614-98-7 Minocycline HCl Arestin Minomycin More... |
Iupac Name: | (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride |
InChI: | InChI=1S/C23H27N3O7.ClH/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28;/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32);1H/t9-,11-,17-,23-;/m0./s1 |
InChIKey: | WTJXVDPDEQKTCV-VQAITOIOSA-N |
Canonical Smiles: | CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl |
Isomeric Smiles: | CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl |
Molecular Weight: | 493.9 |
Molecular Formula: | C23H28ClN3O7 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
MINOCYCLINE HYDROCHLORIDE
Molecular Weight: | 493.9 |
Molecular Formula: | C23H28ClN3O7 |
Hydrogen Bond Donor Count: | 6 |
Hydrogen Bond Acceptor Count: | 9 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 34 |
Complexity: | 971 |
Synonyms
MINOCYCLINE HYDROCHLORIDE
| MINOCYCLINE HYDROCHLORIDE | MINOCYCLINE HYDROCHLORIDE |
|---|---|
MINOCYCLINE HYDROCHLORIDE |
13614-98-7 |
Minocycline HCl |
Arestin |
Minomycin |
Minocin |
Solodyn |
Dynacin |
Periocline |
Minocycline (hydrochloride) |
Vectrin |
Minomax |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride |
UNII-0020414E5U |
Mynocine hydrochloride |
C23H28ClN3O7 |
0020414E5U |
Minocycline, Hydrochloride |
Tri-mino |
DSSTox_CID_24545 |
DSSTox_RID_80306 |
DSSTox_GSID_44545 |
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride |
4S-(4alpha,4aalpha,5aalpha,12aalpha)-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride |
Lederderm |
Mynocine |
Acnez |
Ximino |
Minomycin chloride |
CHEBI:50697 |
(4S-(4alpha,4aalpha,5aalpha,12aalpha))-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride |
4S-(4?,4a?,5a?,12a?)-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide |
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride (1:2), (4S,4aS,5aR,12aS)- |
NSC-141993 |
EINECS 237-099-7 |
Minocycline hydrochloride (internal use) |
C23H27N3O7.HCl |
MFCD00083669 |
Minocycline, HCl |
NCGC00096006-01 |
Prestwick_626 |
Arestin (TN) |
Dynacin (TN) |
Minocin (TN) |
Solodyn (TN) |
Minocycline hydrochloride USP:JAN |
Minocyclinhydrochlorid |
minomycin hydrochloride |
SCHEMBL2537 |
CAS-13614-98-7 |
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,12aalpha))- |
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride |
MLS002548863 |
SPECTRUM1500414 |
7-Dimethylamino-6-demethyl-6-deoxytetracycline, HCl |
FXFM-244 |
CHEMBL1200881 |
CHEMBL4576719 |
DTXSID8044545 |
HMS1568P12 |
Pharmakon1600-01500414 |
BCP06597 |
Tox21_111250 |
Tox21_113183 |
Tox21_301590 |
10118-90-8 (base) |
CCG-40107 |
NSC757120 |
s4226 |
Minocycline hydrochloride, crystalline |
AKOS015951312 |
Minocycline hydrochloride (JP17/USP) |
Tox21_111250_1 |
CS-1256 |
NC00460 |
NSC-757120 |
NCGC00178854-03 |
NCGC00255988-01 |
AC-22362 |
AS-75306 |
HY-17412 |
S051 |
SMR001906766 |
M2288 |
D00850 |
J10198 |
614M987 |
SR-01000075625 |
Q-201407 |
SR-01000075625-1 |
Q27104777 |
Minocycline hydrochloride, Antibiotic for Culture Media Use Only |
Minocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Minocycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
Minocycline hydrochloride, United States Pharmacopeia (USP) Reference Standard |
(4S,12aS,4aS,5aR)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide Hydrochloride |
4S-(4a,4aa,5aa,12aa)-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide |
2-Naphthacenecarboxamide, 4,7- bis(dimethylamino)-1,4,4a,5,5a,6,11,12a- octahydro-3,10,12,12a-tetrahydroxy-1,11dioxo-, monohydrochloride, 4S-(4alpha,4aalpha,5aalpha,12aalpha) |
Experimental Data
MINOCYCLINE HYDROCHLORIDE
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 88 | umol/L | 29 | S | N2 | 24134630 | Active | ||||||
| Caenorhabditis elegans | 33 | umol/L | 29 | S | N2 | 33683565 | Active |
Experimental Data Visualization
MINOCYCLINE HYDROCHLORIDE
Statistics Data
MINOCYCLINE HYDROCHLORIDE
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 29 | 2 | 2 |
Statistics Data Visualization
MINOCYCLINE HYDROCHLORIDE
